Inhibrx Biosciences, Inc.

Inhibrx Biosciences, Inc. financial statements

Inhibrx Biosciences, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 1.3M10-K
Net income−USD 140.06M10-K
Cash and equivalentsUSD 124.22M10-Q
Total debtUSD 100.56M10-Q

Inhibrx Biosciences, Inc. financials on 6ix · Inhibrx Biosciences, Inc. on 6ix